Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Pubmed

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.

Download PDF

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.

Wiviott, Stephen D; Braunwald, Eugene; McCabe, Carolyn H; Horvath, Ivan; Keltai, Matyas; Herrman, Jean-Paul R; Van de Werf, Frans; Downey, William E; Scirica, Benjamin M; Murphy, Sabina A; Antman, Elliott M; ,
The Lancet , Volume 371 (9621): -1289 – May 1, 2008

Loading next page...
 
/lp/pubmed/intensive-oral-antiplatelet-therapy-for-reduction-of-ischaemic-events-qgCC24Jdfy

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0140-6736
eISSN
1474-547X
DOI
10.1016/S0140-6736(08)60422-5
pmid
18377975

Abstract

Journal

The Lancet – Pubmed

Published: May 1, 2008

There are no references for this article.